These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34783463)

  • 1. Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis.
    Fava A; Rao DA; Mohan C; Zhang T; Rosenberg A; Fenaroli P; Belmont HM; Izmirly P; Clancy R; Trujillo JM; Fine D; Arazi A; Berthier CC; Davidson A; James JA; Diamond B; Hacohen N; Wofsy D; Raychaudhuri S; Apruzzese W; ; Buyon J; Petri M
    Arthritis Rheumatol; 2022 May; 74(5):829-839. PubMed ID: 34783463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics.
    Mou L; Zhang F; Liu X; Lu Y; Yue M; Lai Y; Pu Z; Huang X; Wang M
    Front Immunol; 2024; 15():1309447. PubMed ID: 38855105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
    Li Y; Tang C; Vanarsa K; Thai N; Castillo J; Lea GAB; Lee KH; Kim S; Pedroza C; Wu T; Saxena R; Mok CC; Mohan C
    J Autoimmun; 2024 Feb; 143():103165. PubMed ID: 38194790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
    Häyry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
    Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
    J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
    Front Immunol; 2020; 11():671. PubMed ID: 32351512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
    Front Immunol; 2020; 11():256. PubMed ID: 32265898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell profiling reveals kidney CD163
    Chen W; Jin B; Cheng C; Peng H; Zhang X; Tan W; Tang R; Lian X; Diao H; Luo N; Li X; Fan J; Shi J; Yin C; Wang J; Peng S; Yu L; Li J; Wu RQ; Kuang DM; Shi GP; Zhou Y; Wang F; Jiang X
    Ann Rheum Dis; 2024 Apr; 83(5):608-623. PubMed ID: 38290829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients.
    Wang S; Broder A; Shao D; Kesarwani V; Boderman B; Aguilan J; Sidoli S; Suzuki M; Greally JM; Saenger YM; Rovin BH; Michelle Kahlenberg J
    Semin Arthritis Rheum; 2023 Dec; 63():152263. PubMed ID: 37802003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted urine proteomics in lupus nephritis - a meta-analysis.
    Zhang T; Duran V; Vanarsa K; Mohan C
    Expert Rev Proteomics; 2020 Oct; 17(10):767-776. PubMed ID: 33423575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis.
    Fava A; Buyon J; Magder L; Hodgin J; Rosenberg A; Demeke DS; Rao DA; Arazi A; Celia AI; Putterman C; Anolik JH; Barnas J; Dall'Era M; Wofsy D; Furie R; Kamen D; Kalunian K; James JA; Guthridge J; Atta MG; Monroy Trujillo J; Fine D; Clancy R; Belmont HM; Izmirly P; Apruzzese W; Goldman D; Berthier CC; Hoover P; Hacohen N; Raychaudhuri S; Davidson A; Diamond B; ; Petri M
    JCI Insight; 2024 Jan; 9(2):. PubMed ID: 38258904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of receptors for EGF, PDGF, transferrin and folate within murine and human lupus nephritis kidneys.
    Xie S; Louis Sam Titus ASC; Mohan C
    Clin Immunol; 2023 Jan; 246():109188. PubMed ID: 36396012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of urine: implications for lupus nephritis.
    Aljaberi N; Bennett M; Brunner HI; Devarajan P
    Expert Rev Proteomics; 2019 Apr; 16(4):303-313. PubMed ID: 30855196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.
    Landolt-Marticorena C; Prokopec SD; Morrison S; Noamani B; Bonilla D; Reich H; Scholey J; Avila-Casado C; Fortin PR; Boutros PC; Wither J
    Arthritis Res Ther; 2016 Oct; 18(1):218. PubMed ID: 27716443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis.
    Akhgar A; Sinibaldi D; Zeng L; Farris AB; Cobb J; Battle M; Chain D; Cann JA; Illei GG; Lim SS; White WI
    Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36717181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
    Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
    Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis.
    Jakiela B; Kosałka J; Plutecka H; Węgrzyn AS; Bazan-Socha S; Sanak M; Musiał J
    Lupus; 2018 Jul; 27(8):1259-1270. PubMed ID: 29653499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis.
    Fava A; Buyon J; Mohan C; Zhang T; Belmont HM; Izmirly P; Clancy R; Trujillo JM; Fine D; Zhang Y; Magder L; Rao DA; Arazi A; Berthier CC; Davidson A; Diamond B; Hacohen N; Wofsy D; Apruzzese W; ; Raychaudhuri S; Petri M
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32396533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.